| Cerebrospinal fluid β-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain T Tapiola, I Alafuzoff, SK Herukka, L Parkkinen, P Hartikainen, H Soininen, ... Archives of neurology 66 (3), 382-389, 2009 | 1074 | 2009 |
| Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease J Neumann, J Bras, E Deas, SS O'Sullivan, L Parkkinen, RH Lachmann, ... Brain 132 (7), 1783-1794, 2009 | 775 | 2009 |
| Lewy-and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? Y Compta, L Parkkinen, SS O'Sullivan, J Vandrovcova, JL Holton, ... Brain 134 (5), 1493-1505, 2011 | 622 | 2011 |
| Alpha‐synuclein RT‐Qu IC in the CSF of patients with alpha‐synucleinopathies G Fairfoul, LI McGuire, S Pal, JW Ironside, J Neumann, S Christie, ... Annals of clinical and translational neurology 3 (10), 812-818, 2016 | 466 | 2016 |
| Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance L Parkkinen, T Pirttilä, I Alafuzoff Acta neuropathologica 115, 399-407, 2008 | 427 | 2008 |
| Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model S Janezic, S Threlfell, PD Dodson, MJ Dowie, TN Taylor, D Potgieter, ... Proceedings of the National Academy of Sciences 110 (42), E4016-E4025, 2013 | 355 | 2013 |
| Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium I Alafuzoff, PG Ince, T Arzberger, S Al-Sarraj, J Bell, I Bodi, N Bogdanovic, ... Acta neuropathologica 117, 635-652, 2009 | 319 | 2009 |
| Morphogenesis of Lewy bodies: dissimilar incorporation of α-synuclein, ubiquitin, and p62 E Kuusisto, L Parkkinen, I Alafuzoff Journal of Neuropathology & Experimental Neurology 62 (12), 1241-1253, 2003 | 317 | 2003 |
| α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia L Parkkinen, T Kauppinen, T Pirttilä, JM Autere, I Alafuzoff Annals of Neurology: Official Journal of the American Neurological …, 2005 | 313 | 2005 |
| Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies J Bras, R Guerreiro, L Darwent, L Parkkinen, O Ansorge, V Escott-Price, ... Human molecular genetics 23 (23), 6139-6146, 2014 | 245 | 2014 |
| Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study R Guerreiro, OA Ross, C Kun-Rodrigues, DG Hernandez, T Orme, ... The Lancet Neurology 17 (1), 64-74, 2018 | 235 | 2018 |
| Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture R Chia, MS Sabir, S Bandres-Ciga, S Saez-Atienzar, RH Reynolds, ... Nature genetics 53 (3), 294-303, 2021 | 211 | 2021 |
| Testing an aetiological model of visual hallucinations in Parkinson's disease DA Gallagher, L Parkkinen, SS O'Sullivan, A Spratt, A Shah, CC Davey, ... Brain 134 (11), 3299-3309, 2011 | 165 | 2011 |
| Parkin disease: a clinicopathologic entity? KM Doherty, L Silveira-Moriyama, L Parkkinen, DG Healy, M Farrell, ... JAMA neurology 70 (5), 571-579, 2013 | 162 | 2013 |
| Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology NN Vaikath, NK Majbour, KE Paleologou, MT Ardah, E van Dam, ... Neurobiology of disease 79, 81-99, 2015 | 148 | 2015 |
| Regional distribution of α-synuclein pathology in unimpaired aging and Alzheimer disease L Parkkinen, H Soininen, I Alafuzoff Journal of Neuropathology & Experimental Neurology 62 (4), 363-367, 2003 | 137 | 2003 |
| Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study J Attems, JB Toledo, L Walker, E Gelpi, S Gentleman, G Halliday, ... Acta neuropathologica 141, 159-172, 2021 | 133 | 2021 |
| Disentangling the relationship between Lewy bodies and nigral neuronal loss in Parkinson's disease L Parkkinen, SS O'Sullivan, C Collins, A Petrie, JL Holton, T Revesz, ... Journal of Parkinson's disease 1 (3), 277-286, 2011 | 110 | 2011 |
| α‐synuclein genetic variability: A biomarker for dementia in Parkinson disease I Guella, DM Evans, C Szu‐Tu, E Nosova, SF Bortnick, ... Annals of neurology 79 (6), 991-999, 2016 | 106 | 2016 |
| Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases R Guerreiro, V Escott-Price, L Darwent, L Parkkinen, O Ansorge, ... Neurobiology of aging 38, 214. e7-214. e10, 2016 | 103 | 2016 |
